Dyskinesia

Dermatology·MeSH: Dyskinesias

9 drugs in development·8 companies·1 clinical trial

Drug Pipeline by Phase

Approved(5)

Drug	Company
austedo xr	Teva Pharmaceutical Industries Limited (TEVA)
gocovri	Adamas Pharmaceuticals Inc (ADMS)
GOCOVRI	SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Ozagrel Sodium for Injection	CHINA PHARMA HOLDINGS, INC. (CPHI)
valbenazine	Greenwich LifeSciences, Inc. (GLSI)

Phase 3(2)

Drug	Company
Levodopa-carbidopa intestinal gel	AbbVie Inc. (ABBV)
nbi-1065890	NEUROCRINE BIOSCIENCES INC (NBIX)

Phase 1(1)

Drug	Company
oms527	OMEROS CORP (OMER)

Phase 4(1)

Drug	Company
valbenazine	NEUROCRINE BIOSCIENCES INC (NBIX)

BioSniper tracks 9 drugs in development for Dyskinesia across 8 companies.

There are 1 clinical trial targeting Dyskinesia tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.